Lau Bryan, Cole Stephen R, Moore Richard D, Gange Stephen J
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Stat Med. 2008 Sep 20;27(21):4313-27. doi: 10.1002/sim.3293.
A competing risk framework occurs when individuals have the potential to experience only one of the several mutually exclusive outcomes. Standard survival methods often overestimate the cumulative incidence of events when competing events are censored. Mixture distributions have been previously applied to the competing risk framework to obtain inferences regarding the subdistribution of an event of interest. Often the competing event is treated as a nuisance, but it may be of interest to compare adverse events against the beneficial outcome when dealing with an intervention. In this paper, methods for using a mixture model to estimate an adverse-benefit ratio curve (ratio of the cumulative incidence curves for the two competing events) and the ratio of the subhazards for the two competing events are presented. A parametric approach is described with some remarks for extending the model to include uncertainty in the event type that occurred, left truncation in order to allow for time-dependent analyses, and uncertainty in the timing of the event resulting in interval censoring. The methods are illustrated with data from an HIV clinical cohort examining whether individuals initiating effective antiretroviral therapy have a greater risk of antiretroviral discontinuation or switching compared with HIV RNA suppression.
当个体有可能仅经历几种相互排斥的结果之一时,就会出现竞争风险框架。当竞争事件被删失时,标准的生存方法往往会高估事件的累积发生率。混合分布先前已应用于竞争风险框架,以获得有关感兴趣事件的子分布的推断。通常,竞争事件被视为干扰因素,但在处理干预措施时,将不良事件与有益结果进行比较可能会很有意义。本文提出了使用混合模型来估计不良效益比曲线(两个竞争事件的累积发生率曲线之比)以及两个竞争事件的子风险之比的方法。描述了一种参数方法,并给出了一些备注,以扩展模型,使其包括所发生事件类型的不确定性、为进行时间依存性分析而进行的左截断,以及因事件发生时间的不确定性而导致的区间删失。通过来自一个HIV临床队列的数据对这些方法进行了说明,该队列研究开始有效抗逆转录病毒治疗的个体与HIV RNA抑制相比,是否有更高的抗逆转录病毒治疗中断或换药风险。